
Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

San Francisco biotechnology investment partnership using in-house clinical trial analytics

Logos Capital is a biotechnology-focused investment partnership based in San Francisco. It pairs scientific and financial skills with clinical trial analytics done in-house. The name comes from the Greek word for logic and discourse.
Biotechnology companies working on new therapies. Portfolio companies named on its site include Aligos Therapeutics, ALX Oncology, Annexon Biosciences, Athira Pharma and Avidity Biosciences.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Logos Capital.
Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm partnering with founders from first idea through to public listing

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications
Everything here links back to the same verified catalogue. Pick your next stop.